Pittenger & Anderson’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3
Closed -$1.63K – 559
2026
Q2
$1.63K Buy
+3
New +$1.69K ﹤0.01% 478
2022
Q4
– Sell
-5
Closed -$1K – 479
2022
Q3
$1K Hold
5
– – ﹤0.01% 447
2022
Q2
$1K Hold
5
– – ﹤0.01% 430
2022
Q1
$1K Buy
+5
New +$953 ﹤0.01% 447

Other funds holding UTHR

Pittenger & Anderson's UTHR Position: Q3 2026 in Review

Pittenger & Anderson sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 3 shares — an estimated $1.63K sold.

Pittenger & Anderson first reported a position in UTHR in Q1 2022 and held it in 4 quarters. The position peaked at $1.63K in Q2 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Pittenger & Anderson reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Pittenger & Anderson sold 3 United Therapeutics shares in Q3 2026, an estimated $1.63K.
  • Pittenger & Anderson first reported a position in United Therapeutics in Q1 2022 and held it in 4 quarters.
  • Pittenger & Anderson's United Therapeutics position peaked at $1.63K in Q2 2026.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.